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Summary
We report a clinical and genetic study of a family with
a phenotype resembling generalized epilepsy with febrile
seizures plus (GEFS+), described by Berkovic and col-
leagues. Patients express a very variable phenotype com-
bining febrile seizures, generalized seizures often precip-
itated by fever at age 16 years, and partial seizures, with
a variable degree of severity. Linkage analysis has ex-
cluded both the b1 subunit gene (SCN1B) of a voltage-
gated sodium (Na+) channel responsible for GEFS+ and
the two loci, FEB1 and FEB2, previously implicated in
febrile seizures. A genomewide search, under the as-
sumption of incomplete penetrance at 85% and a phe-
nocopy rate of 5%, permitted identification of a new
locus on chromosome 2q21-q33. The maximum pair-
wise LOD score was 3.00 at recombination fraction 0
for marker D2S2330. Haplotype reconstruction defined
a large (22-cM) candidate interval flanked by markers
D2S156 and D2S2314. Four genes coding for different
isoforms of the a-subunit voltage-gated sodium channels
(SCN1A, SCN2A1, SCN2A2, and SCN3A) located in
this region are strong candidates for the disease gene.
Introduction
The estimated prevalence of febrile seizures (FSs) (MIM
121210) in children of age !5 years is 3%–5% (Verity
et al. 1985). Twin and family studies have suggested that
there is an important genetic contribution to the etiology
of this disorder (Hauser et al. 1985; Tsuboi and Endo
1991). Families have been identified in which this trait
segregates with a mode of inheritance compatible with
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a monogenic model. Recently, two loci responsible for
FSs, FEB1 and FEB2, were mapped on chromosomes
8q (Wallace et al. 1996) and 19p (Johnson et al. 1998;
Kugler et al. 1998), respectively. Among children who
experience FSs, 2%–7% develop epilepsy later in life
(Cendes et al. 1995; Maher and McLachlan 1995). A
new familial syndrome named “generalized epilepsy
with febrile seizures plus” (GEFS) has recently been
defined (Scheffer and Berkovic 1997; Singh et al. 1999).
In pedigrees with GEFS, patients present with febrile
seizures that may persist at age 16 years, associated with
afebrile generalized seizures (tonic-clonic seizures, ab-
sences, myoclonic seizures, or atonic seizures) and, some-
times, a mixture of these types of seizures, leading to a
clinical profile of myoclonic-astatic epilepsy. The mode
of inheritance is autosomal dominant with incomplete
penetrance and a high rate of phenocopy. Recently, a
locus was identified, by linkage analysis, on chromosome
19q13, and a mutation was found in the b1-subunit gene
(SCN1B) of a voltage-gated sodium (Na) channel (Wal-
lace et al. 1998).
We report a family in which affected individuals in
three successive generations express variable phenotypes
combining febrile seizures, generalized seizures often
precipitated by fever at age 6 years, and partial seizures,
with a variable degree of severity. This family presents
clinical similarities with families with GEFS that have
been described elsewhere (Scheffer and Berkovic 1997;
Singh et al. 1999). A genomewide search on autosomes,
using semiautomated fluorescent genotyping, permitted
identification of a new GEFS locus on chromosome
2q21-q33.
Subjects and Methods
Subjects
A large nonconsanguineous French family with 13 af-
fected members over 3 generations, as well as 1 affected
spouse, was identified during a national campaign or-
ganized by the French Ge´ne´thon center. A simplified ped-
igree of the family is presented in figure 1. Clinical eval-
uation was performed at the Center of Epileptology of
Figure 1 Partial pedigree of a French family with GEFS, showing haplotype reconstruction for chromosome 2q markers. Deduced haplotypes are bracketed. Microsatellite markers are ordered,
according to the Ge´ne´thon genetic map, from centromere (top) to telomere (bottom). The haplotype segregating with the disease is boxed. Observed recombinations are indicated by arrows.
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Table 1
Pairwise LOD Scores for 10 Markers on Chromosome 2
MARKERa
LOD SCORE AT v =b
.00 .01 .05 .10 .20 .30 .40
D2S142 2.14 .61 .01 .23 .33 .28 .16
D2S284 .45 .27 .10 .30 .42 .36 .21
D2S156 1.70 1.69 1.62 1.49 1.18 .81 .42
D2S382 1.98 1.94 1.76 1.52 1.00 .50 .16
D2S2330 3.00 2.95 2.77 2.51 1.93 1.26 .56
D2S2345 2.11 2.08 1.94 1.74 1.26 .74 .29
D2S335 .65 .65 .65 .62 .47 .26 .09
D2S326 2.17 2.15 2.06 1.91 1.50 .99 .46
D2S2314 .48 .53 .66 .70 .60 .39 .19
D2S2310 1.66 .68 .08 .12 .18 .11 .03
a Order of markers is from telomere (top) to centromere (bottom).
b Maximum LOD scores are underlined.
the Salpeˆtrie`re Hospital (Paris). All members of the fam-
ily or their close relatives were contacted and underwent
clinical assessment by means of a detailed questionnaire.
Information was also obtained retrospectively from
medical records. Electroencephalography (EEG) and
neuroimaging were available for 7 and 6 of 13 patients,
respectively. Informed consent was obtained from all
participants or their legal representatives.
Genotyping
Blood samples from 21 subjects were obtained, and
genomic DNA was extracted, by means of standard pro-
cedures. Family members were genotyped with the fol-
lowing microsatellite markers: D8S553, D8S1840, and
D8S530 and D19S565, D19S591, D19S209, D19S216,
and D19S177, for the FEB1 locus on chromosome 8q
(Wallace et al. 1996) and the FEB2 locus on chromo-
some 19p (Johnson et al. 1998), respectively, which are
two loci responsible for familial FSs. The chromosome
19q locus involved in GEFS was tested with markers
D19S414, D19S868, and D19S425 (Wallace et al.
1998).
A genomewide search was performed with the ABI
PRISM linkage-mapping set, version 2, from PE Bio-
systems. The set consists of 400 fluorescent microsatellite
markers (including 20 markers for chromosome X that
were not tested), selected from the Ge´ne´thon human
linkage map (Weissenbach 1993; Gyapay et al. 1994;
Dib et al. 1996), that cover the entire human genome,
with a resolution of ∼10 cM (Schuster 1998). The mark-
ers were amplified by PCR under the following condi-
tions: 50 ng of genomic DNA, 5 pmol of each primer,
2.5 mM of each dNTP, 1.5 ml of buffer II10# PCR
(1.5 mM MgCl2), and 0.6 U of AmpliTaq Gold DNA
polymerase, in a final volume of 15 ml. Samples were
incubated in a thermocycler for 12 min at 95C, to ac-
tivate the AmpliTaq Gold DNA polymerase; then for 15
s at 94C, 15 s at 55C, and 30 s at 72C, for 10 cycles;
and then for 15 s at 89C, 15 s at 55C, and 30 s at
72C, for 25 cycles, followed by a final extension for 10
min at 72C. After amplification, PCR products from
each set were pooled with the GeneScan 400HD size
standard and were loaded onto a 4% denaturating ac-
rylamide gel, for electrophoresis with the ABI PRISM
377 DNA Sequencer (PE Biosystems). DNA from Centre
d’E´tude du Polymorphisme Human individual 1347-02
was used as an internal control. For fine mapping, five
additional fluorescent markers from the chromosome 2q
were selected from the Ge´ne´thon linkage map. PCR am-
plification was performed as described above.
Linkage Analysis
Pairwise and multipoint LOD scores were calculated
by the MLINK and LINKMAP programs of the FAST-
LINK package, version 3.0 (Schaffer et al. 1994), under
the assumption of an autosomal dominant trait (male-
to-male transmission excluded X-linked inheritance)
with disease-allele frequency of .0001 and incomplete
penetrance. Penetrance, calculated according to the
method of Johnson et al. (1996), was estimated at 85%.
Since the frequency of febrile seizures in the general pop-
ulation is ∼3%–5%, we defined the phenocopy rate as
5%. Recombination fraction (v) values were considered
to be equal in males and females. Since simulation stud-
ies assuming these parameters indicated a maximum
LOD score of 4.01 at , with a five-allele markerv = .00
(equal allele frequencies), a whole-genome scan, exclud-
ing chromosome X, was performed, under the assump-
tion that the frequencies of the alleles observed in the
family studied were equal. For markers with suggestive
linkage, allele frequencies were calculated from a white
population and were determined on the basis of The
Genome Database. For multipoint analysis with markers
from the candidate region, genetic distances from the
Ge´ne´thon linkage map were used: D2S142–8.6 cM–
D2S382–0.6 cM–D2S2330–16.3 cM–D2S2310. Cal-
culations were performed at the Lovelace Infobiogen
Center (Villejuif, France). Haplotypes were recon-
structed according to the principles of Thomson (1987).
The order of markers was that of the consensus Centre
d’E´tude du Polymorphisme Human/Ge´ne´thon chromo-
some 2 linkage map (table 1). The database of the Co-
operative Human Linkage Center was searched for can-
didate genes within the linked interval.
Results
Clinical Data
Clinical data are summarized in table 2. The age at
examination of affected individuals (11 females, includ-
ing spouse III-7, and 3 males) was 12–77 years; 9 had
histories of FS, with onset at age 4 mo–3 years, and 7
Table 2
Clinical Characteristics of Patients
SUBJECT
(SEX, AGE
[YEARS])
FS EPILEPTIC SEIZURES
INTERICTAL EEG
BRAIN IMAGING
(TECHNIQUE)aStatus
Patient Age at
No.
Patient Age at
Pattern No.
First
Occurrence
Last
Occurrence
First
Occurrence
Last
Occurrence
II-1 (F, 69) Unknown ) ) ) 60 years 60 years GTCS 2 Not available Not available
II-2 (F, 76) Unknown ) ) ) Childhood 76 years GTCS Numerous Not available Not available
II-3 (F, 77) Unknown ) ) ) 25 years 30 years GTCS 3 Not available Not available
III-2 (F, 39) Present 9 mo ) Several Childhoodb 32 years GTCSb Numerous Not available Not available
III-5 (F, 32) Present 4 mo ) Numerous Childhoodb 32 years GTCS,b versive seizures
and left hemiclonic
seizures
Numerous Generalized spike-
waves, right frontal
focus
Normal (CT)
III-6 (F, 48) Unknown ) ) ) Childhood 46 years GTCS Several Slow generalized spikes
and waves,
photosensitivity
Normal (CT)
III-7 (F, 41) Present 3 years 3 years 1 ) ) ) ) ) )
III-8 (M, 45) Present 2 years Unknown Several Childhood 7 years GTCS Few Not available Not available
IV-1 (F, 19) Present 1 year 3 years Several 3 years 19 years GTCS absences, absence
status, right hemiclonic
seizures
Numerous Generalized spike-waves,
3-Hz generalized
discharges
Slight cerebellar atro-
phyc (MRI)
IV-2 (F, 18) Present 9 mo 4 years Several ) ) ) ) ) )
IV-3 (F, 23) Present 7 mo ) Numerous 7 mo?b 10 yearsb GTCSb Several Normal Not available
IV-5 (M, 18) Present 1 year ) Several Childhoodb 18 years GTCS,b myoclonic seizures,
atypical absences
Numerous Slow-background, gener-
alized spike-waves
Small right putaminal
ischemic lesion
(MRI)
IV-6 (F, 12) Present 8 mo ) Few Childhoodb 9 years GTCSb Numerous 3-Hz spike-waves Normal (CT)
IV-7 (M, 24) No ) ) ) 24 years 24 years GTCS 4d Normal Normal (CT)
a CT = computed tomography; MRI = magnetic-resonance imaging.
b No symptom-free interval between FS and epileptic seizures, which were often precipitated by fever.
c Perhaps caused by chronic phenytoin treatment.
d One seizure precipitated by sleep deprivation and two seizures precipitated by abrupt cessation of antiepileptic drug.
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Figure 2 Multipoint analysis with chromosome 2q markers in
the French family with GEFS. The genetic distances are represented
as on the Ge´ne´thon chromosome 2 map. Horizontal dotted lines in-
dicate the limit of exclusion (LOD score2) and of significant linkage
(LOD score 3).
of these 9 later developed epilepsy. The number of FS
episodes experienced by each patient was highly vari-
able. Two patients (III-5 and IV-5) had complex FS with
prolonged or multiple attacks over 24-h periods. The
occurrence of FS in the oldest patients (II-1, II-2, II-3,
and III-6) could not be determined. Individual IV-7 never
experienced FS.
In the 12 patients who developed afebrile seizures, the
epilepsy phenotype was variable. The age at which the
first epileptic seizure occurred could be determined for
four individuals (II-1, II-3, IV-1, and IV-7) and was 3–60
years. For the other patients (II-2, III-2, III-5, III-6, III-
8, IV-3, IV-5, and IV-6), age at onset could not be reliably
recorded, because of either lack of precise information
or lack of a seizure-free interval between FS and onset
of epilepsy (with seizures often precipitated by hyper-
thermia) or because of an early association of FS and
afebrile seizures. Generalized tonic-clonic seizures
(GTCSs) occurred in all the epileptic patients. These sei-
zures were associated with absences in two individuals
(IV-1 and IV-5) and with myoclonic seizures (precipi-
tated by carbamazepine) in patient IV-5. In four patients
(III-5, III-6, IV-1, and IV-6), the results of interictal EEG
were suggestive of idiopathic generalized epilepsy (nor-
mal background, generalized 3-Hz spike-waves, and
photosensitivity for individual III-6). For individual IV-
5, generalized spike-waves were associated with a slow
background. In two individuals, some characteristics of
partial seizures were associated with the generalized elec-
troclinical pattern: right hemiclonic seizures in patient
IV-1 and left hemiclonic and versive seizures with an
interictal frontal focus in individual III-5. In both pa-
tients, no focal lesions or brain asymmetries were found
on neuroimaging. Four patients were intellectually im-
paired (severely in the case of individual II-2 and mod-
erately in the case of individuals III-5, IV-1, and IV-5),
and one individual (IV-1) presented a pyramidal syn-
drome on the right side.
There was considerable intrafamilial variation in the
severity of the epileptic disease, with respect to the fre-
quency of seizures, clinical evolution, and response to
antiepileptic drugs. The clinical evolution of seven pa-
tients was favorable. They had been seizure free during
the 2 years preceding our study. Three of these seven
patients were no longer taking antiepileptic drugs (in-
dividuals III-2, III-8, and IV-3), two were receiving
monotherapy (individuals II-1 and II-3), and two were
receiving antiepileptic-drug polytherapy (individuals III-
6 and IV-6). In three patients (II-2, III-5, IV-1), a few
seizures persisted during antiepileptic polytherapy. Pa-
tient IV-5 had pharmacoresistant epilepsy with numer-
ous seizures persisting during antiepileptic polytherapy.
At-risk individuals III-3, III-4, III-10, IV-4, and IV-8 were
clinically normal at ages 44, 41, 56, 24, and 30 years,
respectively, and were considered to be unaffected.
Linkage Analysis
The two loci previously reported for FS, FEB1 on
chromosome 8q (Wallace et al. 1996) and FEB2 on chro-
mosome 19p (Johnson et al. 1998), as well as the first
locus identified for GEFS, on chromosome 19q (Wal-
lace et al. 1998), were first excluded by bipoint and
multipoint analysis (data not shown). A scan of the en-
tire genome, except for the X chromosome, which was
excluded because of a male-to-male transmission, was
conducted, with 380 markers, on the affected individuals
and, when available, their parents. Pairwise LOD scores
were calculated for all markers. Positive pairwise LOD
scores were obtained at , for 35/380 markers.v = .00
They were excluded by haplotype reconstruction and
multipoint analysis, except for two adjacent markers on
chromosome 2. A maximum pairwise LOD score of 2.79
at was generated for marker D2S2330, and av = .00
positive LOD score of 1.46 at was generated forv = .00
marker D2S335. When all the available family members
were included, the pairwise LOD scores reached the sig-
nificant value of 3.00 at for marker D2S2330v = .00
(table 1). The region underwent further analysis, with
an increase of the density of genotyped markers. Positive
LOD scores at for five additional markersv = .00
(D2S156, D2S382, D2S2345, D2S326, and D2S2314)
in this region of chromosome 2 confirmed linkage (table
1). Multipoint analysis with markers D2S142, D2S382,
D2S2330, and D2S2310 generated a LOD score of 3.03
between markers D2S382 and D2S2330 (fig. 2).
Haplotype reconstruction showed that all patients
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except IV-7 and her unaffected mother, III-9, shared
a common haplotype encompassing markers D2S156–
D2S2314. The centromeric boundary of this interval
was defined by a recombination between microsatel-
lites D2S284 and D2S156 in patient IV-1, and the
telomeric boundary was delimited by a recombination
between markers D2S326 and D2S2314 in patient IV-
2. This candidate interval corresponds to a 22-cM
region that is localized on chromosome 2q21-q33, ac-
cording to integrated maps of the Cooperative Human
Linkage Center.
Discussion
The affected members of the family studied present a
very heterogeneous epileptic phenotype, in which febrile
convulsions were variably combined with several pat-
terns of seizures. In some patients, the febrile seizures
were peculiar either because they were associated, early
in life, with afebrile generalized seizures, or because they
persisted with afebrile seizures at age 16 years, as in the
phenotype described and termed “febrile seizures plus”
by Scheffer and Berkovic (1997). Within a family, FS
may be variably associated with either generalized sei-
zures (absences, myoclonic seizures, and atonic seizures)
or clinical features resembling myoclonic-astatic epilepsy
(Singh et al. 1999). The denomination “GEFS” has
been proposed for this new familial syndrome. The phe-
notype of the family that we studied resembles the
GEFS syndrome but is singular because of the presence
of partial seizures that are hemiclonic or versive in two
affected subjects (III-5 and IV-1), suggesting involvement
of the frontal lobe. Temporal-lobe seizures, reported in
some GEFS families by Singh et al. (1999), were not
observed. In addition to focal epileptic symptoms, both
patients display several clinical and electrical features
compatible with generalized idiopathic epilepsy (GTCSs
without focal onset, absences, and/or generalized 3-Hz
spike-waves). Moreover, intellectual impairment is pre-
sent in some individuals of the family (i.e., individuals
II-2, III-5, IV-1, and IV-5). Finally, for six patients (II-
1, II-2, II-3, III-2, III-5, and III-6), seizures appeared or
persisted later in life, compared with their occurrence in
families previously described as having the GEFS
syndrome.
After exclusion of known loci implicated in FS and
GEFS, a scan of all autosomes was undertaken, since
a high rate of phenocopy could be expected in these
syndromes. Pairwise analysis performed for 380 markers
revealed positive LOD scores for 2 adjacent markers on
chromosome 2, which reached a maximum value of 3.00
at for microsatellite D2S2330. Haplotype recon-v = .00
struction indicated that this second locus for GEFS is
restricted to a 22-cM region between markers D2S156
and D2S2314. The presence of the haplotype associated
with the disease in individual III-10, who is still asymp-
tomatic at age 56 years, confirms that the penetrance is
incomplete and/or age dependent. Because of the re-
duced penetrance, the recombination observed in 44
year-old asymptomatic individual III-3 does not defini-
tively restrict the candidate region to the 10.2-cM
interval between D2S156 and D2S2345.
Individual IV-7, who, in the linkage analysis, was con-
sidered to be affected, does not carry the haplotype seg-
regating with the disease in the other patients, nor does
his unaffected mother. He could therefore be considered
to be a phenocopy. The clinical status of this 24-year-
old patient is difficult to interpret: he has no history of
febrile seizures, three of his four seizures were clearly
precipitated by external events (see clinical data in table
2), and his EEG recording was strictly normal before
initiation of antiepileptic-drug treatment. Genetic and
clinical data support the hypothesis that he experienced
provoked seizures rather than spontaneous epilepsy.
Spouse III-7 was also considered to be a phenocopy in
the linkage analysis, since she had only one FS and none
of her relatives were affected, thereby excluding bilineal
inheritance. This hypothesis is supported by the study
by Rich et al. (1987), who showed that individuals with
more than two FSs have a “nearly dominant” inheri-
tance, whereas individuals with only a single FS, most
of whom are sporadic cases, have multifactorial
inheritance.
The identification of a new locus responsible for
GEFS emphasizes the monogenic transmission and the
genetic heterogeneity of this syndrome. A second family
with GEFS linked to the same region has also been
identified (B. Moulard, personal communication), sug-
gesting that this locus might be a frequent cause of the
disease. In addition, the localization, on chromosome 2,
of a gene responsible for a form of idiopathic generalized
epilepsy was reported in an abstract by Lopes-Cendes
et al. (1995). It would be interesting to compare the
phenotype and the chromosomal localization in the fam-
ily that they studied with those in the family that we
studied.
Several genes in the linked region of chromosome
2q21-q33 encode proteins implicated in the regulation
of action potentials in the brain: SCN1A on 2q24,
SCN2A1 on 2q23, SCN2A2 on 2q23-q24, and SCN3A
on 2q24-q31. All four encode isoforms of a brain so-
dium-channel a-subunit (Han et al. 1991; Lu et al. 1992;
Malo et al. 1994a, 1994b). Sodium channels isolated
from vertebrate brain contain a large (230–270 kD)
transmembrane a-subunit and one or two smaller
(33–38 kD) b-subunits (Auld et al. 1988). Functional
studies indicate that the a-subunit is sufficient to form
a functional sodium channel (Hille 1992). These genes
are attractive candidates for the GEFS syndrome in
our family, since a mutation in the b1-subunit gene
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(SCNB1) is known to cause GEFS in another family
(Wallace et al. 1998). GEFS are most probably chan-
nelopathies, as are the vast majority of the familial id-
iopathic epilepsies for which the responsible genes are
known (Steinlein et al. 1995; Charlier et al. 1998; Singh
et al. 1998).
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